Document:

EX-10.1

February 11, 2011

Brandi L. Roberts

9975 Fox Meadow Road

San Diego, California 92127

Dear Brandi:

ADVENTRX Pharmaceuticals, Inc. (the “Company”) is pleased to offer you full-time employment on the
terms and conditions stated in this letter agreement. We would employ you as Vice President,
Finance reporting to Patrick Keran, President and Chief Operating Officer. You acknowledge that,
in this position, you would or may become a “Section 16 reporting person,” which means the Company
would be required to disclose certain personal information about you in its filings with the U.S.
Securities and Exchange Commission and its other public disclosures, and you agree and consent to
the Company’s disclosure of such information. Your responsibilities would include the following:

	 	 	Position Responsibilities:

	•	 	Managing all corporate financial functions including general accounting, internal and
external reporting, financial controls, planning, budgeting, and forecasting.

	•	 	Establishing short term and long term revenue growth potential and profitability parameters
in conjunction with corporate and management objectives.

	•	 	Determining short- and long-term financing requirements for operations.

	•	 	Establishing and maintaining accounting policies, procedures and internal controls in
accordance with US GAAP and SEC rules and regulations.

	•	 	Performing financial modeling and projections, including cost-benefit analysis, pro-forma
P&Ls, balance sheet and cash flows.

	•	 	Preparing and reviewing monthly and quarterly consolidated statements, presenting operating
results and budget variations/reconciliations to Executive Management and the Board of
Directors (or a committee thereof).

	•	 	Managing the cash flow position of the Company.

	•	 	Preparing and updating the annual budget, long-term business plans, and on-going re-forecasts
and projections.

	•	 	Assessing accounting and operational systems/policies to safeguard assets and ensure
financial information is accurately and timely presented.

	•	 	Coordinating with the Company’s independent accounting and legal firms on financial and SOX
audits, tax matters, and SEC filings.

	•	 	Working with the Company’s outside auditors to provide supporting documentation and
information.

	•	 	Overseeing and directing the preparation and issuance of the Company’s annual report, as
applicable.

	•	 	Providing financial analyses for press releases, Board meeting packages and investor
packages.

	•	 	Supporting the Company’s efforts to secure additional financing.

	•	 	Tracking and analyzing new rules and regulations related to financial reporting and
consolidations.

	•	 	Performing other duties as required.

	 	 	General Responsibilities:

	•	 	Operating to the highest ethical and moral standards.

	•	 	Complying with the Company’s policies and procedures.

	•	 	Adhering to quality standards set by regulations, and the Company’s policies and procedures.

	•	 	Communicating effectively with supervisors, colleagues and subordinates.

	•	 	Committing to team effort and willingness to assist in unrelated job areas when called upon.

	•	 	Providing administrative leadership and knowledge-based expertise in related areas that can
be applied to meeting strategic goals.

	•	 	Traveling as needed.

Your initial annual base salary would be $220,000, less payroll deductions and withholding, which
would be payable in accordance with our payroll policies.

We would recommend to our Board of Directors (or a committee thereof) that you be granted an
incentive stock option (to the maximum extent permitted by law and a nonstatutory stock option with
respect to any remaining shares) to purchase 85,000 shares of our common stock under our 2008
Omnibus Incentive Plan. While the final vesting schedule will be determined by our Board of
Directors (or a committee thereof), it is expected that this option would vest monthly over 4
years, except that no shares would vest for one year, at which time 25% of the shares would vest.
We expect that this option would be granted around the time of our 2011 meeting of stockholders.
Your eligibility to receive this option is subject to your accepting E*TRADE Financial Corporate
Services, Inc. (or an affiliate) (“E*TRADE”), on such terms and conditions (including brokerage
commissions) as E*TRADE makes available from time to time or that the Company has or may negotiate
in the future, as your exclusive broker for all options and other securities that may be granted to
you by the Company from time to time. This requirement may not be applicable if you are a “Section
16 reporting person.”

You will be eligible for an incentive award, the target amount of which will be 25% of base salary
earned, based on the Company’s achievement of corporate goals determined from time to time by our
Board of Directors (or a committee thereof) and/or your achievement of personal goals determined
from time to time by you and Mr. Keran. In the event the Company adopts a short-term
incentive/bonus plan in the future, subject to the foregoing, this incentive award will be granted
subject to, but you would otherwise participate as set forth in, such plan on the same terms and
conditions generally applicable to other similarly situated employees of the Company.

As our employee, you would be entitled to participate in our employee benefit programs, including
our medical, dental, life insurance and 401(k) programs, on the same terms as our other full-time
employees. These programs, as well as other employee benefits and policies, are described in
further detail in our Policies and Procedures Manual. We reserve the right to modify or amend at
our sole discretion the terms of any and all employee benefit programs from time to time without
advance notice to our employees. Notwithstanding our employee vacation policy set forth in the
Policies and Procedures Manual, you would be entitled to 20 vacation days per year, which would
accrue in accordance with our general vacation accrual policy, including any maximum accrual limits
set forth therein.

Your employment with us would be “at will” and not for a specified term. We make no express or
implied commitment that your employment will have a minimum or fixed term, that we may take adverse
employment action only for cause or that your employment is terminable only for cause. We may
terminate your employment with or without cause and with or without advance notice at any time and
for any reason. Any contrary representations or agreements that may have been made to you are
superseded by this letter agreement. The at-will nature of your employment described in this
letter agreement shall constitute the entire agreement between you and ADVENTRX concerning the
nature and duration of your employment. Although your job duties, title and compensation and
benefits may change over time, the at-will nature of your employment with us can only be changed in
a written agreement signed by you and our Chief Executive Officer or President.

Our proprietary rights and confidential information are among our most important assets. In
addition to signing this letter agreement, as a condition to your employment you must also sign the
Confidential Information, Non-Solicitation and Invention Assignment Agreement for Employees
presented to you concurrently herewith (the “Company Confidentiality Agreement”). As more fully
described in the Company Confidentiality Agreement, we require that, in the course of your
employment with us, you not use or disclose to us any confidential information, including trade
secrets, of any former employer or other person to whom you have an obligation of confidentiality.
Rather, you will be expected to use only that information which is generally known and used by
persons with training and experience comparable to your own, which is common knowledge in the
industry or otherwise legally in the public domain, or which is otherwise provided or developed by
us. During our discussions about your proposed job duties, you assured us that you would be able
to perform those duties within the guidelines just described. Accordingly, you further agree that
you will not bring on to our premises any unpublished documents or property belonging to any former
employer or other person to whom you have an obligation of confidentiality.

In addition, as an employee, we require that you comply with all of our policies and procedures,
including, without limitation, our Policies and Procedures Manual, Code of Business Conduct and
Ethics and our Insider Trading and Disclosure Policy, copies of which will, at your request, be
provided to you prior to your beginning work with us. You may be required to sign certain
documents acknowledging your receipt and understanding of these and other documents. Violation of
any or our policies or procedures would be cause for disciplinary action including termination.

Your employment with us is also conditioned upon your ability to provide adequate documentation of
your legal right to work in the United States, as well as educational credentials, and successful
completion of our reference checking process. If you make any misrepresentations to us or omit to
state a material fact necessary in order to make another statement made not misleading, we may void
this letter agreement or, if you are already employed, terminate your employment.

This letter agreement and documents attached hereto, if any, or referenced herein shall be governed
pursuant to the laws of the State of California as applied to agreements between California
residents entered into to be performed entirely within California.

If any portion of this letter agreement shall, for any reason, be held invalid or unenforceable, or
contrary to public policy or any law, the remainder of this letter agreement shall not be affected
by such invalidity or unenforceability, but shall remain in full force and effect, as if the
invalid or unenforceable term or portion thereof had not existed within this letter agreement.

If you accept the terms and conditions set forth in this letter agreement, we would like you to
begin work with us immediately following our filing of our annual report on Form 10-K, which we
expect to occur shortly following March 8, 2011. I look forward to you joining us and being an
integral and important part of our team. Please sign below to accept the terms and conditions set
forth herein and return the fully executed letter to me by February 18, 2011. You should keep one
copy of this letter agreement for your own records.

Sincerely,

	 	 	 
	ADVENTRX Pharmaceuticals, Inc.

	 	ACCEPTED AND AGREED:
	/s/ Patrick Keran

	 	/s/ Brandi L. Roberts
	 

	 	 
	Patrick Keran

President and Chief Operating Officer

	 	Brandi L. Roberts

Date: 2/14/11EXHIBIT 10.7

CONVERTIBLE SECURED PROMISSORY NOTE

ISSUE AMOUNT                                                    U.S.  $10,000
FACE AMOUNT                                                     U.S.  $12,000
INTEREST RATE                                                    20% per year
ISSUANCE DATE                                                   June 29, 2010

FOR VALUE RECEIVED, Vital Products, Inc., a Delaware corporation (the
"Company"), hereby promises to pay The Cellular Connection Ltd., an Ontario
corporation, (the "Holder") the Face Amount, subject to further adjustment as
described below, in such amounts, at such times and on such terms and
conditions as are specified herein (this "Note").

Article 1.  Advancement and Fees

The Holder agrees to pay ten thousand dollars ($10,000) to the Company upon
the issuance of this Note as an inducement fee.

Article 2.  Maturity

The Face Amount of this Note is payable June 28, 2011 (the "Maturity
Date").

Notwithstanding any provision to the contrary in this Note, the Company may
pay in full to the Holder the Face Amount, or any balance remaining thereof,
in readily available funds at any time and from time to time without penalty
("Prepayment").

Article 3.  Interest

The outstanding Face Amount of the Note shall increase by 20% on June 28, 2011.
The outstanding Face Amount of the Note shall increase by another 20% on
June 28, 2012 and again on each one year anniversary of June 28, 2012 until
the Note has been paid in full.

Article 4.  Collateral

The Holder may elect to secure a portion of the Company's assets not to
exceed 200% of the Face Amount of the Note, including, but not limited to,
accounts receivable, cash, marketable securities, equipment, building, land
or inventory (the "Collateral").

Article 5.  Defaults and Remedies

Article 5.1.  Events of Default

An "Event of Default" or "Default" occurs if the Company does not pay the
Face Amount of this Note within five (5) business days after the Maturity
Date.

Upon the occurrence of an Event of Default, the Holder may:

* Transfer any or all of the Collateral into its name, or into the name of
its nominee or nominees;

<PAGE>

* Exercise all corporate rights with respect to the Collateral, including,
without limitation, all rights of conversion, exchange, subscription or any
other rights, privileges or options pertaining to any shares of the Collateral
as if it were the absolute owner thereof, including, but without limitation,
the right to exchange, at its discretion, any or all of the Collateral upon
the merger, consolidation, amalgamation, reorganization, recapitalization or
other readjustment of the Company thereof, or upon the exercise by the Company
of any right, privilege or option pertaining to any of the Collateral, and, in
connection therewith, to deposit and deliver any and all of the Collateral
with any committee, depository, transfer agent, registrar or other designated
agent upon such terms and conditions as it may determine, all without liability
except to account for property actually received by it; and

* Subject to any requirement of applicable law including, for greater
certainty, the Personal Property Security Act (Ontario), sell, assign and
deliver the whole or, from time to time, any part of the Collateral at the
time held by the Holder, at any private sale or at public auction, with or
without demand, advertisement or notice of the time or place of sale or
adjournment thereof or otherwise (all of which are hereby waived, except such
notice as is required by applicable law and cannot be waived), for cash or
credit or for other property for immediate or future delivery, and for such
price or prices and on such terms as the Pledgee in its sole discretion may
determine, or as may be required by applicable law.

Article 5.2  Conversion Privilege

(a) The Holder shall have the right to convert the Note into shares of the
    Company's common stock (the "Common Stock") at any time prior to the
    Maturity Date.  The number of shares of Common Stock issuable upon the
    conversion of the Note shall be determined pursuant to Article 5.3.  Any
    fractional shares that occur as a result of conversion shall be rounded up
    or down, as the case may be, to the nearest whole share.

(b) In the event all or any portion of the Note remains outstanding on the
    Maturity Date (the "Residual Amount"), the unconverted portion of such Note
    will automatically be converted into shares of Common Stock on such date in
    the manner set forth in Article 5.3.

Article 5.3 Conversion Procedure.

(a) The Residual Amount may be converted, in whole or in part, any time and
    from time to time, prior to the Maturity Date.  Such conversion shall be
    effectuated by surrendering to the Company, or its attorney, the Note to
    be converted together with a facsimile or original of the signed notice
    of conversion (the "Notice of Conversion").   The date on which the Notice
    of Conversion is effective ("Conversion Date") shall be deemed to be the
    date on which the Holder has delivered to the Company a facsimile or
    original of the signed Notice of Conversion, as long as the original Note
    to be converted is received by the Company within five (5) business days
    thereafter.  At such time that the original Note has been received by the
    Company, the Holder can elect whether a reissuance of the Note is
    warranted, or whether the Company can retain the Note as a continual
    conversion by the Holder.  Notwithstanding the above, any Notice of
    Conversion received on or after 4:00 P.M. EST shall be deemed to have been
    received the following business day (receipt being via a confirmation of
    the time such facsimile to the Company is received).

<PAGE>

(b) Common Stock to be Issued - Upon any conversion of the Note, and upon
    receipt by the Company or its attorney of a facsimile or original of the
    Holder's signed Notice of Conversion, the Company shall instruct its
    transfer agent to issue stock certificates without restrictive legends
    or stop transfer instructions, if at that time the aforementioned
    registration statement described in Article 5.1 has been declared
    effective (or with proper restrictive legends if the registration
    statement has not as yet been declared effective), in such denominations
    to be specified at conversion representing the number of shares of Common
    Stock issuable upon such conversion, as applicable.  In the event that
    the Note is aged one year and deemed sellable under Rule 144, the Company
    shall, upon a Notice of Conversion, instruct the transfer agent to issue
    free trading certificates without restrictive legends, subject to other
    applicable securities laws.  The Company is responsible for all costs
    associated with the issuance of the shares, including, but not limited
    to, fees associated with the opinion letter, FedEx of the certificates
    and any other costs that arise.  The Company shall act as registrar and
    shall maintain an appropriate ledger containing the necessary information
    with respect to the Note.  The Company warrants that no instructions,
    other than these instructions, have been given or will be given to the
    transfer agent and that the Common Stock shall otherwise be freely resold,
    except as may be set forth herein or subject to applicable law.

(c) Conversion Rate - The Holder is entitled to convert the Note, plus accrued
    interest, anytime prior to the Maturity Date, at 75% of the average of the
    lowest closing bid price during the fifteen (15) trading days immediately
    preceding the Conversion Date.  No fractional shares or script representing
    fractions of shares will be issued upon conversion, but rather the number
    of shares issuable shall be rounded up or down, as the case may be, to the
    nearest whole share.

(d) Nothing contained in the Note shall be deemed to establish or require the
    payment of interest to the Holder at a rate in excess of the maximum rate
    permitted by governing law.  In the event that the rate of interest
    required to be paid exceeds the maximum rate permitted by governing law,
    the rate of interest required to be paid thereunder shall be automatically
    reduced to the maximum rate permitted under the governing law and such
    excess shall be returned with reasonable promptness by the Holder to the
    Company.

(e) It shall be the Company's responsibility to take all necessary actions
    and to bear all such costs to issue the Common Stock as provided herein,
    including the responsibility and cost for delivery of an opinion letter to
    the transfer agent, if so required.  The Holder shall be treated as a
    shareholder of record on the date Common Stock is issued to the Holder.  If
    the Holder shall designate another person as the entity in the name of
    which the stock certificates issuable upon conversion of the Note are to
    be issued prior to the issuance of such certificates, the Holder shall
    provide to the Company evidence that either no tax shall be due and payable
    as a result of such transfer or that the applicable tax has been paid by
    the Holder or such person. Upon surrender of any Notes that are to be
    converted in part, the Company shall issue to the Holder a new Note equal
    to the unconverted amount, if so requested in writing by the Holder.

<PAGE>

(f) Within five (5) business days after receipt of the documentation referred
    to above in Article 5.2, the Company shall deliver a certificate for the
    number of shares of Common Stock issuable upon the conversion.  In the
    event the Company does not make delivery of the Common Stock as instructed
    by the Holder within five (5) business days after the Conversion Date,
    then in such event the Company shall pay to the Holder one percent (1%)
    in cash of the dollar value of the amount remaining on the Note after
    said conversion, compounded daily, per each day after the fifth (5th)
    business day following the Conversion Date that the Common Stock is not
    delivered to the Holder.

    The Company acknowledges that its failure to deliver the Common Stock
    within five (5) business days after the Conversion Date will cause the
    Holder to suffer damages in an amount that will be difficult to ascertain.
    Accordingly, the parties agree that it is appropriate to include in this
    Note a provision for liquidated damages.  The parties acknowledge and
    agree that the liquidated damages provision set forth in this section
    represents the parties' good faith effort to quantify such damages, and,
    as such, agree that the form and amount of such liquidated damages are
    reasonable and will not constitute a penalty.  The payment of liquidated
    damages shall not relieve the Company from its obligations to deliver the
    Common Stock pursuant to the terms of this Note.

(g) The Company shall at all times reserve (or make alternative written
    arrangements for reservation or contribution of shares) and have available
    all Common Stock necessary to meet conversion of the Note by the Holder
    of the entire amount of the Note then outstanding.  If, at any time the
    Holder submits a Notice of Conversion and the Company does not have
    sufficient authorized but unissued shares of Common Stock (or alternative
    shares of Common Stock as may be contributed by stockholders of the
    Company) available to effect, in full, a conversion of the Note
    (a "Conversion Default," the date of such default being referred to
    herein as the "Conversion Default Date"), the Company shall issue to
    the Holder all of the shares of Common Stock which are available, and
    the Notice of Conversion as to any Note requested to be converted but
    not converted (the "Unconverted Note") may be deemed null and void upon
    written notice sent by the Holder to the Company.  The Company shall
    provide notice of such Conversion Default ("Notice of Conversion
    Default") to the Holder, by facsimile within three (3) business days
    of such default (with the original delivered by overnight mail or two
    day courier), and the Holder shall give notice to the Company by
    facsimile within five (5) business days of receipt of the original
    Notice of Conversion Default (with the original delivered by overnight
    mail or two day courier) of its election to either nullify or confirm
    the Notice of Conversion.

    The Company acknowledges that its failure to maintain a sufficient
    number of authorized but unissued shares of Common Stock to effect, in
    full, a conversion of the Note will cause the Holder to suffer damages
    in an amount that will be difficult to ascertain.  Accordingly, the
    parties agree that it is appropriate to include in this Note a provision
    for liquidated damages.

<PAGE>

(h) If, by the fifth (5th) business day after the Conversion Date of any
    portion of the Note to be converted (the "Delivery Date"), the transfer
    agent fails for any reason to deliver the Common Stock upon conversion by
    the Holder and after such Delivery Date, the Holder purchases, in an open
    market transaction or otherwise, shares of Common Stock (the "Covering
    Shares") solely in order to make delivery in satisfaction of a sale of
    Common Stock by the Holder (the "Sold Shares"), which delivery such Holder
    anticipated to make using the Common Stock issuable upon conversion
    (a "Buy-In"), the Company shall pay to the Holder, in addition to any
    other amounts due to the Holder pursuant to this Note, and not in lieu
    thereof, the Buy-In Adjustment Amount (as defined below).  The "Buy In
    Adjustment Amount" is the amount equal to the excess, if any, of (x) the
    Holder's total purchase price (including brokerage commissions, if any)
    for the Covering Shares over (y) the net proceeds (after brokerage
    commissions, if any) received by the Holder from the sale of the Sold
    Shares.  The Company shall pay the Buy-In Adjustment Amount to the Holder
    in immediately available funds within five (5) business days of written
    demand by the Holder.  By way of illustration and not in limitation of
    the foregoing, if the Holder purchases shares of Common Stock having a
    total purchase price (including brokerage commissions) of $11,000 to
    cover a Buy-In with respect to shares of Common Stock it sold for net
    proceeds of $10,000, the Buy-In Adjustment Amount which the Company
    will be required to pay to the Holder will be $1,000.

(i) The Company shall defend, protect, indemnify and hold harmless the
    Holder and all of its shareholders, officers, directors, employees,
    counsel, and direct or indirect investors and any of the foregoing
    person's agents or other representatives (including, without limitation,
    those retained in connection with the transactions contemplated by this
    Agreement, collectively, the "Article 5.3(i) Indemnitees") from and
    against any and all actions, causes of action, suits, claims, losses,
    costs, penalties, fees, liabilities and damages, and expenses in
    connection therewith (irrespective of whether any such Article 5.3(i)
    Indemnitee is a party to the action for which indemnification hereunder
    is sought), and including reasonable attorneys' fees and disbursements
    (the "Article 5.3(i) Indemnified Liabilities"), incurred by any
    Article 5.3(i) Indemnitee as a result of, or arising out of, or
    relating to (i) any misrepresentation or breach of any representation
    or warranty made by the Company in this Note or any other certificate,
    instrument or document contemplated hereby or thereby, (ii) any breach
    of any covenant, agreement or obligation of the Company contained in
    this Note or any other certificate, instrument, or document contemplated
    hereby or thereby, (iii) any cause of action, suit, or claim brought or
    made against such Article 5.3(i) Indemnitee by a third party and arising
    out of or resulting from the execution, delivery, performance, or
    enforcement of the Note or any other certificate, instrument, or document
    contemplated hereby or thereby, (iv) any transaction financed or to be
    financed in whole or in part, directly or indirectly, with the proceeds
    of the issuance of the Common Stock underlying the Note, or (v) the
    status of the Holder or holder of the Note as an investor in the Company,
    except insofar as any such misrepresentation, breach or any untrue
    statement, alleged untrue statement, omission, or alleged omission is
    made in reliance upon and in conformity with written information
    furnished to the Company by the Holder which is specifically intended
    by the Holder to be relied upon by the Company, including for use in
    the preparation of any such registration statement, preliminary
    prospectus, or prospectus, or is based on illegal trading of the Common
    Stock by the Holder. To the extent that the foregoing undertaking by the
    Company may be unenforceable for any reason, the Company shall make the
    maximum contribution to the payment and satisfaction of each of the
    Indemnified Liabilities that is permissible under applicable law.  The
    indemnity provisions contained herein shall be in addition to any cause
    of action or similar rights the Holder may have, and any liabilities the
    Holder may be subject to.

<PAGE>

Article 6.  Mergers

    The Company shall not consolidate or merge into, or transfer all or
    substantially all of its assets to, any person, unless such person
    assumes in writing the obligations of the Company under this Note and
    immediately after such transaction no Event of Default exists.  Any
    reference herein to the Company shall refer to such surviving or
    transferee corporation and the obligations of the Company shall terminate
    upon such written assumption.  Failure to do so will constitute an Event
    of Default under this Note and the Holder may immediately seek to take
    actions as described under Article 5 of this Note.

Article 7.  Notices

    Any notices, consents, waivers or other communications required or
    permitted to be given under the terms of this Note must be in writing
    and will be deemed to have been delivered (i) upon receipt, when
    delivered personally, (ii) upon receipt, when sent by facsimile (provided
    a confirmation of transmission is mechanically or electronically generated
    and kept on file by the sending party), or (iii) one (1) day after deposit
    with a nationally recognized overnight delivery service, in each case
    properly addressed to the party to receive the same.

Article 8.  Time

    Where this Note authorizes or requires the payment of money or the
    performance of a condition or obligation on a Saturday or Sunday or a
    holiday in which the United States Stock Markets ("US Markets") are
    closed ("Holiday"), or authorizes or requires the payment of money or the
    performance of a condition or obligation within, before or after a period
    of time computed from a certain date, and such period of time ends on a
    Saturday or a Sunday or a Holiday, such payment may be made or condition
    or obligation performed on the next succeeding business day, and if the
    period ends at a specified hour, such payment may be made or condition
    performed, at or before the same hour of such next succeeding business
    day, with the same force and effect as if made or performed in accordance
    with the terms of this Note.  A "business day" shall mean a day on which
    the US Markets are open for a full day or half day of trading.

Article 9.  No Assignment

    This Note shall not be assigned.

Article 10.  Rules of Construction

    In this Note, unless the context otherwise requires, words in the singular
    number include the plural, and in the plural include the singular, and
    words of the masculine gender include the feminine and the neuter, and
    when the tense so indicates, words of the neuter gender may refer to any
    gender.  The numbers and titles of sections contained in this Note are
    inserted for convenience of reference only, and they neither form a part
    of this Note nor are they to be used in the construction or interpretation
    hereof.  Wherever, in this Note, a determination of the Company is required
    or allowed, such determination shall be made by a majority of the Board of
    Directors of the Company and, if it is made in good faith, it shall be
    conclusive and binding upon the Company and the Holder.

<PAGE>

Article 11.  Governing Law

    The validity, terms, performance and enforcement of this Note shall be
    governed and construed by the provisions hereof and in accordance with the
    laws of the State of Delaware applicable to agreements that are negotiated,
    executed, delivered and performed solely in the State of Delaware.

Article 12.  Waiver

    The Holder's delay or failure at any time or times hereafter to require
    strict performance by Company of any undertakings, agreements or covenants
    shall not waiver, affect, or diminish any right of the Holder under this
    Note to demand strict compliance and performance herewith. Any waiver by
    the Holder of any Event of Default shall not waive or affect any other
    Event of Default, whether such Event of Default is prior or subsequent
    thereto and whether of the same or a different type.  None of the
    undertakings, agreements and covenants of the Company contained in this
    Note, and no Event of Default, shall be deemed to have been waived by the
    Holder, nor may this Note be amended, changed or modified, unless such
    waiver, amendment, change or modification is evidenced by an instrument
    in writing specifying such waiver, amendment, change or modification and
    signed by the Holder.

Article 13.  Senior Obligation

    The Company shall cause this Note and all other existing Notes with the
    Holder ("Holder's Debt") to be senior in right of payment to all other
    indebtedness of the Company.

Article 14.  Miscellaneous

(a) All pronouns and any variations thereof used herein shall be deemed to
    refer to the masculine, feminine, impersonal, singular or plural, as the
    identity of the person or persons may require.

(b) Neither this Note nor any provision hereof shall be waived, modified,
    changed, discharged, terminated, revoked or canceled, except by an
    instrument in writing signed by the party effecting the same against whom
    any change, discharge or termination is sought.

(c) This Note may be executed in two or more counterparts, all of which taken
    together shall constitute one instrument.  Execution and delivery of this
    Note by exchange of facsimile copies bearing the facsimile signature of a
    party shall constitute a valid and binding execution and delivery of this
    Note by such party.  Such facsimile copies shall constitute enforceable
    original documents.

(d) This Note represents the FINAL AGREEMENT between the Company and the
    Holder and may not be contradicted by evidence of prior, contemporaneous,
    or subsequent oral agreements of the parties, there are no unwritten oral
    agreements among the parties.

 <PAGE>

(e) The execution, delivery and performance of this Note by the Company and
    the consummation by the Company of the transactions contemplated hereby and
    thereby will not (i) result in a violation of the Certificate of
    Incorporation, any Certificate of Designations, Preferences and Rights of
    any outstanding series of preferred stock of the Company or the By-laws,
    or (ii) conflict with, or constitute a material default (or an event which
    with notice or lapse of time or both would become a material default)
    under, or give to others any rights of termination, amendment, acceleration
    or cancellation of, any material agreement, contract, indenture mortgage,
    indebtedness or instrument to which the Company or any of its Subsidiaries
    is a party, or result in a violation of any law, rule, regulation, order,
    judgment or decree, including United States federal and state securities
    laws and regulations and the rules and regulations of the principal
    securities exchange or trading market on which the Common Stock is traded
    or listed (the "Principal Market"), applicable to the Company or any of
    its Subsidiaries or by which any property or asset of the Company or any
    of its Subsidiaries is bound or affected.

    Any misrepresentations shall be considered a breach of contract and
    Default under this Note and the Holder may seek to take actions as
    described under Article 5 of this Note.

                            [signature page follows]

IN WITNESS WHEREOF, the Company has duly executed this Note as of the Issuance
Date first written above.

VITAL PRODUCTS, INC.                    The Cellular Connection Ltd.

By: /s/Michael Levine                   By: /s/Stuart Turk
---------------------                   --------------------
Name:  Michael Levine                   Name: Stuart Turk
Title:    CEO                           Title:   President

<PAGE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]